Key facts
- Custom Surgical’s last known valuation is $10.7M (Nov 2023).
- It has raised $7.1M; the latest was Later Stage VC ($4.2M) in Feb 2026.
- Notable investors include Plug and Play Tech Center, Ventech (Paris), NextCorps Luminate, ZEISS International, Constructor University Bremen — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Custom Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Custom Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Custom Surgical
Developer of a medical imaging system designed to digitize surgical microscopes and slit-lamps and enhance their functionalities with mobile applications. The company's system provides eye care diagnosis and surgery analysis with artificial intelligence and augmented reality, and has a database of ophthalmic images and microscopic videos, which improves surgical and diagnostic procedures, enabling doctors to easily detect and treat diseases.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2019
- Employees
- 16
- Website
- customsurgical.co/
- Ownership
- Privately Held (backing)
Custom Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Custom Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Custom Surgical in its N-PORT filings yet. We sweep new filings monthly.